ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,484.77
      0.97%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cellect Biotechnology Ltd (APOP)

      7. Cellect Biotechnology Ltd (APOP) News

      APOP

      Cellect Biotechnology (APOP)

      Cellect Biotechnology Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:APOP
      DateTimeSourceHeadlineSymbolCompany
      02/16/20219:43AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APOPCellect Biotechnology Ltd
      02/11/202111:52AMEdgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:APOPCellect Biotechnology Ltd
      01/13/20219:04AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APOPCellect Biotechnology Ltd
      11/20/20208:00AMGlobeNewswire Inc.Cellect Biotechnology Reports Third Quarter Financial and Operating Results; Recent Developments Position Company to Accelera...NASDAQ:APOPCellect Biotechnology Ltd
      11/09/20208:12AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      10/29/20208:00AMGlobeNewswire Inc.Cellect Biotechnology Commences Collaboration with XNK Therapeutics to Advance Novel NK Cell-Based Therapies; Adds Another Pa...NASDAQ:APOPCellect Biotechnology Ltd
      10/22/20208:00AMGlobeNewswire Inc.Cellect Biotechnology Initiates U.S. Clinical Trial of ApoGraftNASDAQ:APOPCellect Biotechnology Ltd
      10/20/20204:02PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      10/13/20206:21AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      09/25/20204:04PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      09/21/20208:32AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      09/21/20208:30AMGlobeNewswire Inc.Cellect Biotechnology to Present at the 2020 Cell & Gene Meeting on the MesaNASDAQ:APOPCellect Biotechnology Ltd
      08/12/20208:19AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      08/12/20208:00AMPR Newswire (US)Cellect Biotechnology Reports Second Quarter Financial and Operating Results; First Half 2020 Strategic Developments Create L...NASDAQ:APOPCellect Biotechnology Ltd
      08/06/20208:50AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      08/06/20208:30AMPR Newswire (US)European Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem Cells ActivationNASDAQ:APOPCellect Biotechnology Ltd
      08/04/20203:22PMEdgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:APOPCellect Biotechnology Ltd
      06/03/202012:07PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      05/27/20208:56AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      05/21/20204:28PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      05/21/20204:15PMPR Newswire (US)Cellect Biotechnology Reports First Quarter 2020 Financial and Operating Results; Continues to Demonstrate Significant Progre...NASDAQ:APOPCellect Biotechnology Ltd
      05/21/20204:00PMGlobeNewswire Inc.Cellect Biotechnology Reports First Quarter 2020 Financial and Operating Results; Continues to Demonstrate Significant Progre...NASDAQ:APOPCellect Biotechnology Ltd
      05/18/20208:05AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      05/18/20208:00AMPR Newswire (US)Cellect Biotechnology's ApoGraft™ to Empower Cellular Treatment of COVID-19 Related Pulmonary DiseasesNASDAQ:APOPCellect Biotechnology Ltd
      05/12/20202:33PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
      05/12/20202:19PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      05/12/20208:48AMGlobeNewswire Inc.Cellect Biotechnology Announces Exercise of Warrants for Cash Proceeds of Approximately $1.5 MillionNASDAQ:APOPCellect Biotechnology Ltd
      05/11/20206:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      05/11/20202:13AMPR Newswire (US)Cellect Biotechnology Announces Positive Data Demonstrating Robust Engraftment Using ApoGraft was Featured in Bone Marrow Tra...NASDAQ:APOPCellect Biotechnology Ltd
      04/27/20208:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
       Showing the most relevant articles for your search:NASDAQ:APOP